• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,155.62 347.14
( 0.45%)
Global Indices
Nasdaq
52,022.73 330.70
(0.64%)
Dow Jones
7,531.82 -43.47
(-0.57%)
Hang Seng
69,975.80 571.30
(0.82%)
Nikkei 225
10,504.45 73.83
(0.71%)
Forex
USD-INR
94.63 -0.29
(-0.31%)
EUR-INR
109.79 -0.04
(-0.03%)
GBP-INR
127.09 -0.16
(-0.13%)
JPY-INR
0.59 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
338.0498657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
40.62
38458.31
EPS(TTM)
Face Value()
Div & Yield %
75.78
2
0.91
 

Colgate-Palmolive (India) standalone net profit declines 0.47% in the March 2026 quarter
May 22,2026
Net profit of Colgate-Palmolive (India) declined 0.47% to Rs 353.32 crore in the quarter ended March 2026 as against Rs 355.00 crore during the previous quarter ended March 2025. Sales rose 9.00% to Rs 1582.77 crore in the quarter ended March 2026 as against Rs 1452.02 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.76% to Rs 1325.31 crore in the year ended March 2026 as against Rs 1436.81 crore during the previous year ended March 2025. Sales declined 0.26% to Rs 5983.57 crore in the year ended March 2026 as against Rs 5999.20 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1582.771452.02 9 5983.575999.20 0
OPM %32.2034.30 -31.2532.64 -
PBDT525.69515.99 2 1954.992092.58 -7
PBT490.61477.62 3 1808.931929.84 -6
NP353.32355.00 0 1325.311436.81 -8